Location of Repository

Potential for Thermal Enhancement by Quercetin Mediated Mechanisms Targeting p53 Antagonists in Human Melanoma Cells

By T. Thangasamy, K. Limesand, D. B. Leeper and R. Burd


Introduction: Recently Temozolomide (TMZ) has become the more commonly used analog of DTIC-related oral agents. Although the response rates achieved by TMZ alone are less than satisfactory, there is great interest in identifying compounds that could be used in combination therapy. We have previously demonstrated that the bioflavonoid quercetin (Qct) promotes a p53-mediated response in melanoma and sensitizes melanoma to DTIC. Here we demonstrate that Qct also sensitizes cells to TMZ by a mechanism that involves the modulation of a truncated p53 family member, ΔNp73. Society for Thermal Medicine Annual Meeting April 23-26, Clearwater Beach, FL

Topics: Thermal Enhancement, Quercetin Mediated Mechanisms, p53 Antagonists, Human Melanoma Cells, Thomas Jefferson University, Oncology
Publisher: Jefferson Digital Commons
Year: 2010
OAI identifier: oai:jdc.jefferson.edu:bodinejournal-1005

Suggested articles


To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.